The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance

With the emergence of sodium-glucose cotransporter 2 inhibitors (SGLT2i), the treatment of type 2 diabetes mellitus (T2DM) has achieved a new milestone, of which the insulin-independent mechanism could produce weight loss, improve insulin resistance (IR) and exert other protective effects. Besides t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Meiyuan, Chen, Huiling, Wen, Song, Yuan, Yue, Yang, Liling, Li, Yanyan, Yuan, Xinlu, Xu, Dongxiang, Zhou, Ligang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938665/
https://www.ncbi.nlm.nih.gov/pubmed/36820270
http://dx.doi.org/10.2147/DMSO.S399367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938665/
https://www.ncbi.nlm.nih.gov/pubmed/36820270
http://dx.doi.org/10.2147/DMSO.S399367

Ejemplares similares